Feasibility of Combating Antimicrobial Resistance using One Health Approach

ผู้แต่ง

  • Rajesh Bhatia Former Director, Communicable Diseases, WHO Regional Oice for South East Asia, New Delhi, India

บทคัดย่อ

       In recent years, antimicrobial resistance (AMR) has assumed global health importance. Inability of current antimicrobial agents available to treat common and life-threatening infections is gradually pushing humanity to dark ages of post antibiotic era. It is no longer a medical problem since global community considers it as a development and economic issue. The Sustainable Development Goals articulate a commitment to launch well-coordinated multi-sectoral actions to combat AMR. Apart from developing new and afordable antimicrobial agents, which are both expensive and time consuming, the rational and reduced use of antibiotics is also a key element of any strategies to minimize impact of AMR. Huge quantities of antimicrobial agents are used in a veterinary sector, mainly as growth promoters. These are instrumental in giving rise to resistance in pathogens for critically important antimicrobial agents, thus putting human health at grave risk. A comprehensive One Health approach that addresses the use of antimicrobials in humans, animals and environment is the solution to comprehensively address the growing menace of AMR across the world, especially in developing countries.

References

WHO. At UN, global leaders commit to act on antimicrobial resistance. [Online]. 2016 [cited 2017 Aug 13]; [2 screens]. Available from: URL: https://www.who.int/mediacentre/news/releases/2016/commitment-antimicrobial-resistance/en.

Sustainable Development. Transforming our world: the 2030 agenda for Sustainable Development. [Online]. 2016 [cited 2017 Aug 13]; [18 screens]. Available from: URL: https://sustainabledevelopment.un.org/post2015/transformingourworld.

WHO. Global action plan on antimicrobial resistance. [Online]. 2015 [cited 2017 Aug 13]; [28 screens]. Available from: URL: https://www.who.int/antimicrobial-resistance/global-action-plan/en.

Tackling drug-resistant infections globally: inal report and recommendations. [Online]. 2016 [cited 2017 Aug 11]; [84 screens]. Available from: URL: https://amr-review.org/sites/default/iles/160525_Final%20paper_with%20cover.pdf.

World Bank. By 2050, drug-resistant infections could cause global economic damage on par with 2008 inancial crisis. [online]. 2016 [cited 2017 Aug 10]; [3 screens]. Available from: URL: https://www.worldbank.org/en/news/press-release/2016/09/18/by-2050-drug-resistant-infectionscould-cause-global-economic-damage-on-par-with-2008-inancial-crisis.

Van Boeckel TP, Brower C, Gilbert M, Grenfell BT, Levin SA., Robinson TP, et al. Global trends in antimicrobial use in food animals. PNAS 2015; 112(18): 5649-54.

Landers TF, Cohen B, Wittum TE, Larson EL. A Review of antibiotic use in food animals: perspective, policy, and potential. Public Health Rep 2012; 127: 4-22.

Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J, Doi Y, et al. Emergence of plasmidmediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 2016; 16(2): 161-8.

Brower CH, Mandal S, Hayer S, Sran M, Zehra A, Patel SJ, et al. The prevalence of extended-spectrum beta-lactamase-producing multidrug-resistant Escherichia coli in poultry chickens and variation according to farming practices in Punjab, India. Environ Health Perspect 2017; 125(7): 077015.

Bhatia R, Narain JP. The growing challenge of antimicrobial resistance in the South-East Asia region -- Are we losing the battle? Indian J Med Res 2010; 132(5): 482-6.

Downloads

เผยแพร่แล้ว

29-12-2017

ฉบับ

บท

บทความพิเศษ (Special Articles)